FOXO (FOXO Technologies) Research & Development: $0.19 Mil (TTM As of Mar. 2026)


What is FOXO Technologies Research & Development?

FOXO Technologies FOXO -50.00% Research & Development is $0.19 Mil as of Mar. 2026. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. FOXO Technologies's Research & Development for the three months ended in Mar. 2026 was $0.04 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.19 Mil.

FOXO Technologies  (OTCPK:FOXO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

FOXO Technologies Research & Development Related Terms

FOXO Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for FOXO Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FOXO Technologies Research & Development Chart

FOXO Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 4.88 3.05 0.90 0.31 0.18

FOXO Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.04 0.08 0.04 0.04

FOXO Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.19 Mil mean?
FOXO Technologies (FOXO) has a Research & Development of $0.19 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on FOXO Technologies and its competitors.
Is FOXO Technologies' Research & Development too high?
FOXO Technologies' current Research & Development is $0.19 Mil.
How does FOXO Technologies' Research & Development compare to WORX and MSPR?
FOXO Technologies' Research & Development of $0.19 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on FOXO Technologies and its competitors. FOXO Technologies's current Research & Development is $0.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FOXO Technologies stock overvalued right now?
Based on GuruFocus' analysis, FOXO Technologies (FOXO) is currently considered Possible Value Trap. The stock's GF Value™ is $5.87, compared to a current price of $0.00 — trading 100% below its estimated fair value. The current Research & Development is $0.19 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For FOXO Technologies (FOXO), the current Research & Development is $0.19 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FOXO Technologies Business Description

Address 477 South Rosemary Avenue, Suite 224, West Palm Beach, FL, USA, 33401
FOXO Technologies Inc is a healthcare services and technology company. It currently operates four synergistic divisions: (i) a rural hospital division; (ii) a mental and behavioral health division; (iii) an information, data and biospecimen sourcing division; and (iv) an epigenetics diagnostics and interpretation division. The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs. Myrtle, RCHI and SCCH operate under the Healthcare segment and Vector operates under the Life Science Services segment. The company generates majority of its revenue from Healthcare segment. It includes RCHI's hospital, BSF, has 25 inpatient beds, and a 24/7 emergency department and provides ancillary services.